HER2 missense mutations have distinct effects on oncogenic signaling and migration.
about
Molecular Mechanisms and Translational Therapies for Human Epidermal Receptor 2 Positive Breast CancerERBB2 mutations associated with solid variant of high-grade invasive lobular breast carcinomas.SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis.Identification and Validation of Driver Kinases from Next-Generation Sequencing Data.HER2 Reactivation through Acquisition of the HER2 L755S Mutation as a Mechanism of Acquired Resistance to HER2-targeted Therapy in HER2+ Breast Cancer.PIK3CA mutations and TP53 alterations cooperate to increase cancerous phenotypes and tumor heterogeneity.Intrinsic HER2 V777L mutation mediates resistance to trastuzumab in a breast cancer patient.Neratinib for the treatment of breast cancer.Structural investigations on mechanism of lapatinib resistance caused by HER-2 mutants.HER2 is not a cancer subtype but rather a pan-cancer event and is highly enriched in AR-driven breast tumors.Clinical and pathological characterization of HER2 mutations in human breast cancer: a systematic review of the literature.Genomic alterations of ERBB receptors in cancer: clinical implications.HER kinase inhibition in patients with HER2- and HER3-mutant cancers.Activating HER2 mutations as emerging targets in multiple solid cancers.
P2860
Q28072513-80E13718-08F8-403A-8B89-1B860B1255E8Q37687387-57B12F33-D9A6-475A-834A-603561CA7E5CQ37697914-0CFC010C-A3D9-4545-B319-D400CDFCCFEDQ38668707-05BC4A86-2CAA-4D0D-8AC8-76298F58353EQ38704133-34BEA684-F488-4BA5-A723-469DB8371276Q38716747-17C2D944-31FE-4AB7-819A-FE8E5B0E980EQ39143829-2F0FBA2C-0FCE-45CD-B09F-301DF3F1DA61Q39333848-68F93985-DFD2-47E5-85E9-BF01CC4AA505Q48042475-0511832F-1480-416C-8D75-4000F61A936DQ48139829-80DFE1A8-6A35-4449-AB91-D0B217E0D5B4Q48316419-AC355312-2E58-45C6-B736-D9F54EED38BEQ49678076-1A55DA77-57A8-4975-998A-5BD64374E3DCQ50115014-9362B47A-E3EB-4EF8-A1C6-D4DAB20995B4Q54986604-D5BF0051-2FBC-4068-A3B7-694E8E817FA6
P2860
HER2 missense mutations have distinct effects on oncogenic signaling and migration.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
HER2 missense mutations have distinct effects on oncogenic signaling and migration.
@ast
HER2 missense mutations have distinct effects on oncogenic signaling and migration.
@en
type
label
HER2 missense mutations have distinct effects on oncogenic signaling and migration.
@ast
HER2 missense mutations have distinct effects on oncogenic signaling and migration.
@en
prefLabel
HER2 missense mutations have distinct effects on oncogenic signaling and migration.
@ast
HER2 missense mutations have distinct effects on oncogenic signaling and migration.
@en
P2093
P2860
P50
P356
P1476
HER2 missense mutations have distinct effects on oncogenic signaling and migration
@en
P2093
Ashley Cimino-Mathews
Ben Ho Park
Berry Button
Bracha Erlanger
Carlos L Arteaga
D Marc Rosen
Daniel J Zabransky
Heather A Parsons
Hong Yuen Wong
P2860
P304
P356
10.1073/PNAS.1516853112
P407
P577
2015-10-27T00:00:00Z